Imagine Naloxone for Alcohol
GOA26 is a first-in-class combination injectable two-stage combination drug candidate for treating alcohol poisoning and intoxication by rapidly and safely eliminating alcohol and its toxic metabolites.
Enzyme metabolizes ethanol to acetaldehyde
Chemical formulation sequesters acetaldehyde
In IND-enabling studies in porcine models, GOA26 lowered blood alcohol concentrations by over 60% at 20 minutes post-administration compared with the control group.
GOA26 is being developed initially for intravenous administration in acute-care medical settings, followed by plans for self-administered formulations for broad consumer use.
